Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2017

Aug 15, 2017

34519_dirs_2017-08-14_5f4f325d-3b64-4766-bdae-8fb38c319be7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2017-08-10

Reporting Person: Rhodes Linda (Former Director Resigned)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.10 share 7157 Direct

Footnotes

F1: This figure includes 1,009 shares of common stock held by an immediate family member of Dr. Rhodes, to which Dr. Rhodes disclaims beneficial ownership.